The Collameta collagen tripeptide has been announced by Glanbia Nutritionals as a new product created in partnership with Jellice Co. that's formulated to support optimal absorption and more.
The high-potency collagen is reported to absorb four-times after than alternatives and deliver 10-times the efficacy of traditional collagen peptides. The patented formulation is suited for use in a variety of applications including ready-to-drink (RTD) beverages, drink mixes, tablets, gummies, capsules and more. The product also allows for the reduction of dosage when compared to collagen peptides thanks to its enhanced absorption rate.
Associate Strategic Product Manager Rachel Schreck spoke on the Collameta collagen tripeptide saying, "We are excited to bring Collameta to market because it provides a much higher percentage of bioactive tripeptide than other tripeptides on the market. Formulating with collagen has been a challenge because standard collagen peptides are too big to be absorbed directly, resulting in a larger dose and limitations on certain applications."
High-Potency Collagen Products
The Collameta Collagen Tripeptide Absorbs Four-Times Faster
Trend Themes
1. Enhanced Collagen Bioavailability - High-potency collagen products like Collameta significantly improve bioactive tripeptide levels, making supplements more effective.
2. Multiform Applications - Collameta's flexible formulation allows it to be incorporated into diverse product types, from RTD beverages to gummies and capsules.
3. Reduced Dosage Requirements - By boosting absorption rates, Collameta reduces the required dosage, enabling cost-effective and convenient supplementation options.
Industry Implications
1. Nutritional Supplements - The growing demand for more potent and easily absorbed collagen supplements is reshaping the nutritional supplement industry.
2. Functional Beverages - Functional beverage manufacturers are integrating advanced collagen formulations like Collameta to offer health benefits in convenient drink formats.
3. Pharmaceuticals - Pharmaceutical companies are exploring high-absorption bioactive tripeptide collagen for advanced therapeutic applications and formulations.